These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3577932)

  • 1. Immunoglobulin-mediated cytotoxic effect of ALS-plasma towards erythrocytes: reflexion of a pathogenetic mechanism?
    Conradi S; Ronnevi LO
    Adv Exp Med Biol; 1987; 209():7-13. PubMed ID: 3577932
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature and properties of cytotoxic plasma activity in amyotrophic lateral sclerosis.
    Ronnevi LO; Conradi S; Karlsson E; Sindhupak R
    Muscle Nerve; 1987 Oct; 10(8):734-43. PubMed ID: 3683447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of immunosuppression on cytotoxic activity in amyotrophic lateral sclerosis.
    Conradi S; Ronnevi LO
    Clin Neuropharmacol; 1987 Jun; 10(3):280-6. PubMed ID: 3454718
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantitation of red cell-bound immunoprotein.
    Sokol RJ; Hudson G
    Transfusion; 1998 Aug; 38(8):782-95. PubMed ID: 9709788
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of immune processes in amyotrophic lateral sclerosis pathogenesis.
    Alexianu ME
    Rom J Neurol Psychiatry; 1995; 33(3-4):215-27. PubMed ID: 8729177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
    Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
    Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Amyotrophic lateral sclerosis: an autoimmune disease?].
    Hansen PR; Werdelin LM
    Ugeskr Laeger; 1991 Feb; 153(8):565-6. PubMed ID: 2008740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further studies on the erythrocyte uptake of lead in vitro in amyotrophic lateral sclerosis (ALS) patients and controls. Abnormal erythrocyte fragility in ALS.
    Ronnevi LO; Conradi S; Nise G
    J Neurol Sci; 1982; 57(1):143-56. PubMed ID: 6818331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased fragility of erythrocytes from amyotrophic lateral sclerosis (ALS) patients provoked by mechanical stress.
    Ronnevi LO; Conradi S
    Acta Neurol Scand; 1984 Jan; 69(1):20-6. PubMed ID: 6702416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer experiments in amyotrophic lateral sclerosis.
    Denys EH; Jackson JE; Aguilar MJ; Wilson AJ; Norris FH
    Arch Neurol; 1984 Feb; 41(2):161-3. PubMed ID: 6691817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osmotic haemolysis in amyotrophic lateral sclerosis.
    Galli S; Sessa A; Pirotta G; De Caro L; Poloni M; Mazzini L; Pinelli P
    Adv Exp Med Biol; 1987; 209():135-7. PubMed ID: 3577901
    [No Abstract]   [Full Text] [Related]  

  • 12. A characteristic ganglioside antibody pattern in the CSF of patients with amyotrophic lateral sclerosis.
    Stevens A; Weller M; Wiethölter H
    J Neurol Neurosurg Psychiatry; 1993 Apr; 56(4):361-4. PubMed ID: 7683329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity in plasma from patients with amyotrophic lateral sclerosis.
    Overgaard K; Werdelin L; Sørensen H; Mogensen P; Boysen G
    Neurology; 1991 Jun; 41(6):925-7. PubMed ID: 2046943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous glomerulonephropathy associated with psoriasis vulgaris.
    Sakemi T; Hayashida R; Ikeda Y; Baba N; Nishihara G; Kohda H
    Nephron; 1996; 72(2):351-2. PubMed ID: 8684567
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum anti-neuronal antibodies in amyotrophic lateral sclerosis.
    Çoban A; Ulusoy C; Giriş M; Turan S; Türkoğlu R; Tüzün E; Idrisoğlu HA
    Int J Neurosci; 2013 Aug; 123(8):557-62. PubMed ID: 23461588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis: current concepts and management.
    Arnason BG
    Hosp Pract (Off Ed); 1982 Feb; 17(2):81-9. PubMed ID: 6210614
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity.
    Ho BK; Alexianu ME; Colom LV; Mohamed AH; Serrano F; Appel SH
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6796-801. PubMed ID: 8692898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for peripheral immune activation in amyotrophic lateral sclerosis.
    Chen X; Feng W; Huang R; Guo X; Chen Y; Zheng Z; Shang H
    J Neurol Sci; 2014 Dec; 347(1-2):90-5. PubMed ID: 25312013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity in Guamanians with amyotrophic lateral sclerosis and parkinsonism-dementia.
    Hoffman PM; Robbins DS; Oldstone MB; Gibbs CJ; Gajdusek DC
    Ann Neurol; 1981 Aug; 10(2):193-6. PubMed ID: 7283404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneally administered IgG from patients with amyotrophic lateral sclerosis or from an immune-mediated goat model increase the levels of TNF-α, IL-6, and IL-10 in the spinal cord and serum of mice.
    Obál I; Klausz G; Mándi Y; Deli M; Siklós L; Engelhardt JI
    J Neuroinflammation; 2016 May; 13(1):121. PubMed ID: 27220674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.